Hessel van der Weide

Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles

Hessel van der Weide, Denise M. C. Vermeulen-de Jongh, Aart van der Meijden et al. · International Journal of Antimicrobial Agents · 2019 · 47 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Therapeutic Efficacy of Novel Antimicrobial Peptide AA139-Nanomedicines in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats

Hessel van der Weide, Unai Cossío, Raquel Gracia et al. · Antimicrobial Agents and Chemotherapy · 2020 · 39 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumon iae and P. aeruginosa

Hessel van der Weide, Jlenia Brunetti, Alessandro Pini et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 2017 · 36 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Antibiotic-Nanomedicines: Facing the Challenge of Effective Treatment of Antibiotic-Resistant Respiratory Tract Infections

Jeffrey A. S. Ritsema, Hessel van der Weide, Yvonne M. te Welscher et al. · Future Microbiology · 2018 · 20 citations · Full text

Pharmacy, Infectious Diseases, Pharmaceutics +17

Differences in Systemic IgA Reactivity and Circulating Th Subsets in Healthy Volunteers With Specific Microbiota Enterotypes

Christina Großerichter-Wagener, Djawad Radjabzadeh, Hessel van der Weide et al. · Frontiers in Immunology · 2019 · 19 citations · Full text

Life Sciences, Immunology, Microbiology +16